Director buying at NanoSphere Health Science (NSHS)

Director buying at NanoSphere Health Science (C:NSHS)

Updated Thursday Dec 20, 2018 01:54 AM EDT
Sutton Robert, a Director, acquired 1,166,666 Common Shares on a control or direction basis for registered holder Preferred Holdings Group, LLC at a price of $0.300 through a prospectus or prospectus exempt offering on December 17th, 2018. The insider also acquired 1,166,666 Warrants with an exercise price of $0.580 for 24 months. This represents a $350,000 investment into the company's shares and an account share holdings change of 3.8%.

NanoSphere Health Science is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.

Nanosphere Health Sciences Inc (NanoSphere), formerly Corazon Gold Corp is Canada-based company engaged in medicinal and botanical manufacturing sector. The Company is commercializing its disruptive, nanoparticle delivery system platforms for cannabis under the brand Evolve Formulas available in a number of accounts throughout Colorado. Evolve has already launched its NanoSerum product for the recreational and medical cannabis markets in Colorado. NanoSerum is the clinically tested transdermal cannabis product to relieve pain. The Company is owner of NanoSphere Health Sciences LLC which is, a biotechnology firm specializing in the creation of the NanoSphere Delivery System, a platform using nanotechnology in the biodelivery of supplements, nutraceuticals and over-the-counter medications for the cannabis, pharmaceutical and animal health industries.


Top